{
    "nct_id": "NCT04258566",
    "official_title": "A Feasibility Study to Evaluate the Combination of Electromagnetic Tracking and Optical Imaging With Indocyanine Green (ICG) for Hepatic Biopsies",
    "inclusion_criteria": "* INCLUSION CRITERIA:\n\nIn order be eligible to participate in this study, an individual must meet all of the following criteria:\n\n* Patients must have imaging findings consistent with hepatocellular carcinoma or other liver neoplasms or metastasis, for whom image-guided percutaneous biopsy is planned as clinically indicated or IRB-approved under a separate research protocol.\n* Patients must have at least one lesion that can readily be biopsied per Principal Investigator.\n* Age >18 years.\n* Patients must have the ability to understand and the willingness to sign a written informed consent document.\n* Evidence of post-menopausal status or negative urinary or serum pregnancy test for female pre-menopausal patients. Women will be considered post-menopausal if they verbally report amenorrhea for 12 months without an alternative medical cause, or have had surgery or received chemicals to induce menopause.\n\nEXCLUSION CRITERIA:\n\n* History of hypersensitivity reactions to Indocyanine Green (ICG), iodinated contrast, or sulfur-containing compounds.\n* Pregnant women and nursing mothers are excluded from this study because of exposure to radiation from CT scanning associated with the biopsy\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that, in the opinion of the Principal Investigator, would limit compliance with study requirements\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 100 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}